This FDA-regulated prospective RCT enrolled 304 patients at 14 US centers to compare lumbar total disc replacement (CHARITÉ artificial disc) vs. instrumented ALIF (BAK cages with iliac crest autograft) for single-level L4-S1 degenerative disc disease unresponsive to ≥6 months of conservative care, following patients for 24 months with ODI, VAS, and SF-36 outcomes.
This study forms the evidence base for offering total disc replacement to appropriate candidates with single-level L4-S1 degenerative disc disease.
The data support counseling patients that disc replacement offers at least equivalent pain relief and functional improvement compared to fusion, with potentially faster recovery and higher long-term satisfaction rates.
This FDA-regulated prospective RCT enrolled 304 patients at 14 US centers to compare lumbar total disc replacement (CHARITÉ artificial disc) vs. instrumented ALIF (BAK cages with iliac crest autograft) for single-level L4-S1 degenerative disc disease unresponsive to ≥6 months of conservative care, following patients for 24 months with ODI, VAS, and SF-36 outcomes.
This study forms the evidence base for offering total disc replacement to appropriate candidates with single-level L4-S1 degenerative disc disease.
The data support counseling patients that disc replacement offers at least equivalent pain relief and functional improvement compared to fusion, with potentially faster recovery and higher long-term satisfaction rates.